RecruitingNot ApplicableNCT07080697

A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension

The Impact of Splenectomy on Debridement Efficacy, Perioperative Recovery, and Prognosis in Patients With Acute Necrotizing Pancreatitis Complicated by Pancreatic Sinistral Portal Hypertension


Sponsor

Zhejiang University

Enrollment

66 participants

Start Date

Jul 30, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a prospective, single-center, randomized controlled trial focusing on patients with acute necrotizing pancreatitis (ANP) complicated by pancreatic sinistral portal hypertension (PSPH). The study aims to study the impact of total splenectomy on the debridement efficacy, perioperative recovery, and prognosis of patients with ANP complicated by PSPH.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether removing the spleen (splenectomy) during surgical debridement — a procedure to remove infected or dead tissue — leads to better outcomes in patients with severe acute pancreatitis (a serious inflammation of the pancreas) that is complicated by a specific type of high blood pressure in the veins near the pancreas and spleen. **You may be eligible if...** - You are between 18 and 75 years old - You have acute necrotizing pancreatitis (severe pancreas inflammation with tissue death) complicated by left-sided portal hypertension (high pressure in the veins near the spleen) - You are having open surgery to remove infected pancreatic tissue **You may NOT be eligible if...** - You had pre-existing heart, lung, liver, kidney, or other organ failure before your pancreatitis - You had pre-existing liver cirrhosis or other conditions that could already cause high blood pressure in the portal veins - You had a pre-existing blood disorder - You are having laparoscopic (keyhole) or nephroscopic surgery instead of open surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESplenectomy

Open Debridement combined with distal pancreatectomy and total splenectomy

PROCEDUREControl

Open Debridement alone


Locations(1)

First Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07080697


Related Trials